Home/Pipeline/Genetic Disease Sponsorship Program

Genetic Disease Sponsorship Program

Rare Disease (e.g., Fabry, TK2d)

CommercialActive

Key Facts

Indication
Rare Disease (e.g., Fabry, TK2d)
Phase
Commercial
Status
Active
Company

About Genomenon

Genomenon is a private, revenue-generating company that provides a software and data platform to bridge the gap between the vast, rapidly growing body of genomic literature and actionable clinical and research insights. Its core technology, the Mastermind Genomic Intelligence Platform and the Cancer Knowledgebase (CKB), uses AI to index and curate evidence on millions of genetic variants, serving both diagnostic labs and biopharma clients. By transforming unstructured literature into structured, searchable evidence, Genomenon aims to increase diagnostic yield, de-risk drug development, and advance precision medicine.

View full company profile

Therapeutic Areas